# Apparius > Apparius is a Paris-based investment bank (corporate finance advisory boutique) founded in 2010, specialised in healthcare and deeptech companies. It advises founders, management teams and shareholders on sell-side and buy-side M&A, LBO/MBO and capital raising, from Series A to growth rounds. Apparius (Apparius Corporate Finance) — SARL, 102 avenue des Champs-Élysées, 75008 Paris, France. Website in French (default) and English. Contact through the form on the website. ## Practices - Mergers & acquisitions: sell-side and buy-side advisory, with strategic and financial acquirers, in France and abroad. - LBO & MBO: advising management teams and shareholders on leveraged and management buyouts. - Capital raising: from Series A to growth rounds, with venture capital, growth equity and strategic investors. ## Sectors - [Healthcare](https://www.apparius.co/en/healthcare/): medical devices, surgical robotics, digital health, healthcare services. - [Deeptech](https://www.apparius.co/en/deeptech/): breakthrough and industrial technologies — semiconductors, materials, energy, environment, robotics. ## Team - Cédric Goarant — Managing Partner - Henri de Lalande — Partner - Kiko Filipov — Partner · Head of Healthcare Venture - Yoann Foray — Senior Vice President - Jérôme Pascal — Senior Advisor - Biographies: https://www.apparius.co/en/team/ ## Selected transactions Full list with details: https://www.apparius.co/en/transactions/ - 2026 — eCential Robotics (Surgical navigation and robotics, Healthcare): Binding acquisition offer (€155M EV) from Enovis (announced). Apparius role: exclusive advisor to the company. - 2026 — Axinesis (Rehabilitation assets of Axinesis, Healthcare): Acquired by Dessintey. Apparius role: exclusive advisor to the buyer. - 2025 — Dessintey (Rehabilitation devices, Healthcare): LBO with Arlane. Apparius role: exclusive advisor to the sellers. - 2025 — Juisci (AI-curated scientific information, Healthcare): Series A from Ring Capital, Big Pi Ventures. Apparius role: exclusive advisor to the company. - 2024 — IBS – Innovative Ion Implant (Semiconductors, Deeptech): Acquired by Ardian. Apparius role: exclusive advisor to the sellers. - 2024 — SurgAR (3D surgical registration, Healthcare): €11M Series A from Bpifrance, XAnge, Elaia. Apparius role: exclusive advisor to the company. - 2024 — SpinEM Robotics (Robotic spinal surgery navigation, Healthcare): €10M strategic investment from Spineart. Apparius role: financial advisor to management. - 2024 — Inopsys (Industrial wastewater treatment, Deeptech): Acquired by Indaver. Apparius role: exclusive advisor to the sellers. - 2023 — Agir à dom (French home care provider, Healthcare): Minority investment from Crédit Agricole. Apparius role: exclusive advisor to the company. - 2023 — Cosmo Tech (Complex systems simulation, Deeptech): Series C from Accenture. Apparius role: exclusive advisor to the company. - 2023 — Imactis (CT navigation systems, Healthcare): Acquired by GE HealthCare. Apparius role: exclusive advisor to the sellers. - 2022 — Aniah (Integrated circuit design error detection, Deeptech): €3M Series A from Supernova Invest, BNP Paribas Développement, Crédit Agricole. Apparius role: exclusive advisor to the company. - 2022 — LabWise (Digital TV testing, Deeptech): Acquired by Allegro DVT. Apparius role: exclusive advisor to the buyer. - 2021 — Waga Energy (Landfill gas to biomethane, Deeptech): €126M IPO on Euronext. Apparius role: advisor to the founders. - 2021 — BA Healthcare (Design and assembly of robotic systems, Healthcare): MBO sponsored by BNP Paribas Développement, Financière Fonds Privés. Apparius role: exclusive advisor to management. - 2021 — Xenocs (Nanomaterial characterisation, Deeptech): Growth investment from Capza. Apparius role: exclusive advisor to the company. - 2021 — UroMems (Artificial urinary sphincters, Healthcare): €23M Series B extension from btov, Financière Arbevel, Bpifrance, HIL-INVENT, Wellington Partners, Supernova Invest. Apparius role: exclusive advisor to the company. - 2021 — eCential Robotics (Bone surgery robotics, Healthcare): Series C from Bpifrance, Trail, MedInnov. Apparius role: exclusive advisor to the company. - 2020 — UroMems (Artificial urinary sphincters, Healthcare): €12.5M Series B from btov, Financière Arbevel, Bpifrance, HIL-INVENT, Wellington Partners, Supernova Invest. Apparius role: exclusive advisor to the company. - 2020 — Naïo Technologies (Autonomous weeding robots, Deeptech): €14M Series B from Bpifrance, Capagro, Pymwymic, Demeter. Apparius role: exclusive advisor to the company. - 2019 — Diabeloop (Artificial pancreas, Healthcare): €31M Series B from CEMAG Invest, Odyssée Venture, Crédit Agricole, Supernova Invest, UI Investissement, Agir à dom. Apparius role: exclusive advisor to the company. - 2019 — Waga Energy (Landfill gas to biomethane, Deeptech): €10M Series B from Aliad, Tertium, Starquest, Ovive. Apparius role: exclusive advisor to the company. - 2019 — Amphion (Video compression, Deeptech): Acquired by Allegro DVT. Apparius role: exclusive advisor to the buyer. - 2019 — Therapixel (AI medical imaging, Healthcare): €5M Series A from M Capital, Crédit Agricole, Omnes, Région Sud Invest. Apparius role: exclusive advisor to the company. - 2018 — Cosmo Tech (Complex systems simulation, Deeptech): €18M funding round from Inven Capital, Cemag Invest, C. Entrepreneurs. Apparius role: exclusive advisor to the company. - 2018 — MDoloris Medical Systems (Pain monitoring, Healthcare): €9M Series A from Seventure, XAnge. Apparius role: exclusive advisor to the company. - 2018 — Elistair (Tethered drones, Deeptech): €2M funding round from Starquest Capital. Apparius role: exclusive advisor to the company. - 2018 — eCential Robotics (Bone surgery robotics, Healthcare): €10.5M Series A from Bpifrance, Trail, MedInnov. Apparius role: exclusive advisor to the company. - 2018 — Orthotaxy (Orthopaedic surgical robotics, Healthcare): Acquired by Johnson & Johnson. Apparius role: exclusive advisor to the sellers. - 2017 — Imactis (Interventional radiology, Healthcare): €3M Series A from M Capital, BNP Paribas, Crédit Agricole. Apparius role: exclusive advisor to the company. - 2017 — BioSerenity (Portable health monitoring, Healthcare): €15M Series B from LBO France, Bpifrance, Eurazeo. Apparius role: exclusive advisor to the company. - 2017 — Open Health (Health data, Healthcare): €5M Series A from LBO France. Apparius role: exclusive advisor to the company. - 2016 — UroMems (Urology, Healthcare): €12M Series B from Supernova Invest, Bpifrance, b2venture, Wellington Partners, CITA. Apparius role: exclusive advisor to the company. - 2016 — eCential Robotics (Bone surgery robotics, Healthcare): Seed round from MedInnov. Apparius role: exclusive advisor to the company. - 2015 — Avenisense (Embedded sensors, Deeptech): €2.5M funding from ALIAD, Demeter Partners, Total Energy Ventures, Bpifrance. Apparius role: exclusive advisor to the company. - 2015 — Oros (Noise and vibration analysis instruments, Deeptech): Acquired by T&S Technologies (TSTech). Apparius role: exclusive advisor to the sellers. - 2015 — Cruas / Agrivolt (Photovoltaic asset, Deeptech): Acquired by Cap Vert Énergie. Apparius role: exclusive advisor to the sellers. - 2014 — eNovance (Open-source cloud orchestration, Deeptech): Acquired by Red Hat. Apparius role: exclusive advisor to the sellers. - 2014 — Cosmo Tech (Complex systems simulation, Deeptech): €3.8M funding round from Aster Capital, Sofimac Partners, Crédit Agricole Création. Apparius role: exclusive advisor to the company. - 2013 — eNovance (Open-source cloud orchestration, Deeptech): €6M financing from Odyssée Venture, Entrepreneur Venture, BNP Paribas, Oséo. Apparius role: exclusive advisor to the company. ## Case studies - [eCential Robotics: from seed round to Enovis offer](https://www.apparius.co/en/healthcare/#story-ecential) (2016 – 2026) - [Imactis sold to GE HealthCare](https://www.apparius.co/en/healthcare/#story-imactis) (2023) - [Orthotaxy acquired by Johnson & Johnson](https://www.apparius.co/en/healthcare/#story-orthotaxy) (2018) - [From Waga Energy's €10M round to its IPO](https://www.apparius.co/en/deeptech/#story-waga) (2019 – 2021) - [Cosmo Tech, from first round to Series C](https://www.apparius.co/en/deeptech/#story-cosmo-tech) (2014 – 2023) - [From eNovance's first round to its $100M exit](https://www.apparius.co/en/deeptech/#story-enovance) (2010 – 2014) ## Pages - [Home (French)](https://www.apparius.co/) - [Home (English)](https://www.apparius.co/en/) - [Transactions](https://www.apparius.co/en/transactions/) - [Team](https://www.apparius.co/en/team/) - [Legal notice](https://www.apparius.co/en/legal/)